Bladder & bowel care for healthcare professionals - Coloplast UK

NHS Patient Safety Alert on Bowel Care Pathways

NHS Improvement has issued a Patient Safety Alert requiring all NHS healthcare providers treating patients with neurogenic bowel dysfunction to ensure that policies, procedures and appropriately trained staff are in place to meet patient needs by 25th January 2019.

Read more on how Coloplast can support healthcare providers in adhering to the Alert (pdf)

The Cost of Constipation

Bowel Interest Group, 2020. Cost of Constipation 3rd Edtion. Available here:

Peristeen should be considered when:

  • First-line treatments (e.g. laxatives, diet changes) fail to provide sufficient relief

  • The patient is within the principle bowel dysfunction patient groups: neurogenic, functional, paediatric

  • Patient assessments have been conducted and the patient is engaged

Regulated by the Care Quality Commission (CQC)


Sample request

Thank you

Your sample request has been received successfully

View desktop version